Study on interventing effect of puerarin on insulin resistance of type 2 diabetes mellitus
- VernacularTitle:葛根素治疗非胰岛素依赖型糖尿病患者胰岛素抵抗的研究
- Author:
Huimin HAN
;
Shuguo WANG
- Publication Type:Journal Article
- Keywords:
puerarin;
type 2 diabetes mellitus;
insulin resistance
- From:
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
2006;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the effects of puerarin on insulin resistance (IR) and abormal lipid and fibrinolytic activity in patients with type 2 diabetes mellitus (DM). Methods: Eighty patients with type 2 DM were divided randomly into two groups: 40 cases in the puerarin group and 40 cases in the routine treatment group. The conventional treatment of the two groups were the same. Additionally, patients in the puerarin group were given puerarin 500 mg in 250 ml of normal saline for intravenous dripping, once a day with a therapeutic course of 3 weeks. The changes of fast blood glucose (FBG), lipid, insulin and plasminogen activator inhibitorCD*21 (PAICD*21) activity were measured before and after treatment,and the insulin sensitivity index (ISI) was calculated. Forty healthy subjects were taken as controls. Results: ①After 3 weeks of treatment , compared with the control group, in type 2 DM patients, FBG, fast insulin (FINS), total cholesterol (TC), triglyerides (TG), low-density lipoprotein cholesterol (LDLCD*2C) levels and PAICD*21 activity were higher, ISI and HDLCD*2C were lower than those of the healthy controls. FINS and ISI were well correlated with lipid and fibrinolytic abnormality. ②After puerarin treatment, FINS, TC, TG, LDLCD*2C level , and PAICD*21 activity decreased and ISI, HDLCD*2C increased significantly (all P
